A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42:775 80. 32. Anavekar NS, Tleyjeh IM, Anavekar NS, et al. Impact of prior antiplate- let therapy on risk of embolism in infective endocarditis. Clin Infect Dis. 2007;44:1180 6. 33. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke. 2005;36:1588 93. 34. He J, Whelton PK, Vu B, et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA. 1998;280:1930 5. 35. Werner M, Andersson R, Olaison L, et al. A clinical study of culture-nega- tive endocarditis. Medicine (Baltimore). 2003;82:263 73. 36. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: in- ternational guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296 327. 37. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:2369 413. 38. Park CB, Greason KL, Suri RM, et al. Fate of nonreplaced sinuses of Valsalva in bicuspid aortic valve disease. J Thorac Cardiovasc Surg. 2011;142:278 84. 39. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient character- istics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162:90 4. 40. Tleyjeh IM, Abdel-Latif A, Rahbi H, et al. A systematic review of popula- tion-based studies of infective endocarditis. Chest. 2007;132:1025 35. 41. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocar- ditis on pacemaker leads: clinical presentation and management. Circula- tion. 1997;95:2098 107. 42. Lalani T, Chu VH, Park LP, et al. 